Zanteris
Tailored Strategies for Accelerated Drug Development

In the landscape of pharmaceutical and biotechnology firms, the need for effective solutions and operational excellence is more critical than ever for achieving favorable results in drug development and clinical trials. As the industry races to develop life-changing therapies, the demands of expediency, precision, and quality have surged to the forefront.

Zanteris, a clinical project and vendor management consultancy company, stands poised at the vanguard of this transformation. It offers an extensive suite of services, covering everything from clinical trial setup and execution to vendor selection and contracting, up to the finalization of the clinical study reports (CSR).

With a proactive approach and a commitment to building customised strategies, it has carved a niche for itself with its tailored solutions for pharmaceutical, biotech companies and contract research organisations seeking to navigate the intricate world of drug development and clinical trials with speed and ease.

“As a consulting firm rather than a CRO, our core mission is providing best-in-class advisory services to accelerate and optimize the drug development process for our clients,” says Mike Failly, managing director of Zanteris.

Acknowledging the distinct character and drug development needs of each client, Zanteris is resolute in its dedication to adapting to their company culture along with a solution-oriented mindset. By taking a consultative approach, it offers unbiased guidance tailored to address each client’s unique needs and objectives across their clinical programs.

Its team’s expertise spans a spectrum of domains, encompassing cost-efficiency strategies within clinical operation departments, with an exclusive focus on fast-tracking clinical project initiation and completion.

Zanteris’ solutions are structured around three key pillars—clinical project management, life science consulting, and human efficiency. Its services include providing resources such as consultant or contractor for clinical project management. It offers consultative support across the entire spectrum, from initial proposals to CSR preparation.

The consultancy also strongly emphasises elevating the efficacy and capabilities of clinical project managers and their teams. This involves fostering the development of leadership skills and executing curated growth programs to enhance internal communications and, subsequently, the quality of deliverables.

To gain profound insights about its clients, Zanteris conducts comprehensive assessments and handpicks the most suitable strategies in alignment with their objectives. The key is conducting assessments such as operational, organizational, vendor oversight, data analytics, or risks to gain a comprehensive understanding of each client’s specific needs. It rigorously reviews standard operating procedures (SOPs), defines effective quality management systems (QMS), and assesses ongoing activities to identify the root causes of specific issues. The diligent process enables it to leverage its insights to achieve the desired outcomes effectively.

Zanteris supports clients in achieving marketing authorisation, a goal closely linked to delivering high-quality data. This central objective highlights its dedication to quality initiatives and a variety of activities aimed at supporting pharma and biotech companies in preparing for inspections. Its services span critical activities, including SOP compliance, regulatory requirements adherence, comprehensive data integrity oversight, mitigate risks and ensuring full compliance with all relevant aspects during clinical trial commencement and up to completion.

Its services are underpinned by diligent oversight. An organisation experienced this first-hand when they faced issues related to cleaning data while attempting to achieve a database lock. The Zanteris team thoroughly examined the issue and implemented improvements in the clinical monitoring strategy and operational efficiency. These changes improved customer oversight and contributed to progress in strategy development and implementations, ultimately achieving the database lock ahead of schedule.

While providing client assistance remains an essential aspect of its services, Zanteris’ primary focus is to guide organizations to maximize opportunities and overcome challenges within the complex clinical trials environment. The overarching goal is delivering operational efficiencies, enabling clients to redirect their focus toward enhancing overall drug development and scientific priorities.

Guided by the mission of expediting drug development, Zanteris offers tailored solutions and operational excellence to empower clients to consistently achieve high-quality results in clinical trials. Its blend of experience and expertise has enabled it to become a sought-after partner in the clinical trial management space.